Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
Summary
The purpose of this study is to examine the impact of timed cortisol release or differently timed cortisol rhythms on insulin resistance in both men and women undergoing sleep restriction. Chronic sleep loss is highly prevalent, affecting 1 in 3 adults in the US. Chronic sleep loss causes stress which induces insulin resistance and leads to obesity and type 2 diabetes. Many factors contribute to sleep loss including shift work, environmental disturbances, sleep/circadian disorders and comorbid medical and mental health conditions. Sleep loss increases the stress hormone cortisol in the evening and decreases daytime testosterone. Examining these hormones in a controlled laboratory environment under different sleep schedules may help researchers find solutions for adults experiencing negative health consequences related to chronic sleep loss.
Timeline
- Start
- 2026-07-01
- Primary completion
- 2029-03
- Completion
- 2029-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrocortisone | Other / unclassified | 0.5 mg | Subcutaneous |
| Comparator | Hydrocortisone | Other / unclassified | 2.3 mg | Subcutaneous |
| Comparator | Hydrocortisone | Other / unclassified | 4 mg | Subcutaneous |
| Comparator | Metyrapone | Small molecule | 500 mg | Oral |
| Comparator | Dextrose | Unknown | 300 mg/kg | Intravenous |
| Comparator | Insulin | Protein / enzyme biologic | 0.03 iu/kg | Intravenous |